You are here: Industry Insights > cPass

News List

GenScript Announces Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Kit prnasia
July 29, 2021
GenScript Biotech Corporation announced that the U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application covering a novel Surrogate Virus Neutralization Test (sVNT).
Duke-NUS and GenScript Announce Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Test prnasia
June 22, 2021
GenScript Biotech Corporation announced that the U.S. Patent and Trade Office has issued a notice of allowance for the patent application for a novel Surrogate Virus Neutralization Technology (sVNT).
GenScript, Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate to provide cPass(TM) SARS-CoV-2 Neutralizing Antibody Testing Service in Singapore prnasia
April 12, 2021
GenScript Biotech Corporation, Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test in Singapore through Parkway's panel of specialist and GP clinics.
Duke, GenScript, A*STAR Enter COVID-19 Pact contractpharma
May 19, 2020
Launch SARS-CoV-2 serology test to detect neutralizing antibodies without need of containment facility or specimen.